Neoplasm
Not recruitingStudy on Vemurafenib for Patients with Advanced Cancers with BRAF Gene Changes
- Disease:Neoplasm
- Substances:Vemurafenib
France- Participants:18–64 years · 65+ years
- Substances:Vemurafenib
- Sponsor:Unicancer
Rare diseases
Investigational molecules
Locations
Back to France676 clinical trials in Angers, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
France
France
France
France
France
France
France
France
France
France
France
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on multiple myeloma, breast cancer, and various forms of lung cancer. Studies are evaluating new combination therapies and treatment approaches for both early-stage and advanced cancers.
Research includes investigation of novel drug combinations and immunotherapy approaches.
Clinical research addressing heart failure prevention and acute myocardial infarction management. Studies are exploring innovative pain management approaches and preventive treatments.
Focus on both acute care solutions and long-term prevention strategies.
Comprehensive research in kidney transplantation and immune disorders, including studies on preventing rejection and managing immunosuppression.
Trials aim to improve long-term outcomes for transplant recipients and immune disorder patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.